US00091G1040 - Common Stock - After market: 6.54 0 (0%)
Date | Firm | Action | Rating |
---|---|---|---|
2022-06-30 | JMP Securities | Reiterate | Market Outperform |
2022-06-10 | Barrington Research | Initiate | Outperform |
2022-06-10 | Goldman Sachs | Maintains | Buy |
2022-05-18 | JMP Securities | Maintains | Market Outperform |
2022-05-12 | Needham | Maintains | Buy |
2022-05-12 | Stephens & Co. | Maintains | Overweight |
2022-05-12 | Truist Securities | Maintains | Buy |
2022-05-12 | Goldman Sachs | Maintains | Buy |
2022-03-02 | Stephens & Co. | Upgrade | Equal-Weight -> Overweight |
2022-03-01 | Needham | Initiate | Buy |
2022-01-07 | Goldman Sachs | Initiate | Buy |
2021-12-07 | JP Morgan | Maintains | Overweight |
2021-10-29 | Truist Securities | Initiate | Buy |
2021-08-23 | Citigroup | Upgrade | Neutral -> Buy |
2021-08-18 | Piper Sandler | Upgrade | Neutral -> Overweight |
2021-08-13 | B of A Securities | Upgrade | Neutral -> Buy |
2021-08-04 | JP Morgan | Upgrade | Neutral -> Overweight |
2021-04-19 | Guggenheim | Initiate | Buy |
2021-04-19 | JMP Securities | Initiate | Market Outperform |
2021-04-19 | Raymond James | Initiate | Market Perform |
2021-04-19 | JP Morgan | Initiate | Neutral |
2021-04-19 | Canaccord Genuity | Initiate | Buy |
2021-04-19 | Piper Sandler | Initiate | Neutral |
2021-04-19 | Citigroup | Initiate | Neutral |
2021-04-19 | Jefferies | Initiate | Buy |
2021-04-16 | Stephens & Co. | Initiate | Equal-Weight |
2021-03-29 | Northcoast Research | Initiate | Neutral |
Find the competitors with the best analyst ratings on the USA